Search

everythinglearnresearchcommunity

for

Search:↓

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Cell adhesion molecules are important in the development of certain skin diseases.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

No treatment showed clear superiority for lichen planopilaris.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Lichen planus is linked to several autoimmune diseases.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.